N

Nanoform Finland Oyj
OMXH:NANOFH

Watchlist Manager
Nanoform Finland Oyj
OMXH:NANOFH
Watchlist
Price: 1.23 EUR 1.49% Market Closed
Market Cap: 105.2m EUR
Have any thoughts about
Nanoform Finland Oyj?
Write Note

Nanoform Finland Oyj
Investor Relations

Nanoform Finland Oyj engages in providing expert services in nanotechnology and drug particle engineering for the international pharma industry. The company is headquartered in Helsinki, Etela-Suomen and currently employs 158 full-time employees. The company went IPO on 2020-06-04. The firm is an early-stage growth Company that develops various nanoforming technologies for application in the field of nanomedicine. Nanoform Finland Oyj’s business is to offer expert services in nanotechnology as well as drug particle engineering for global pharma and biotech industry. Nanoform Finland Oyj is the Parent Company of the Nanoform Group, and it has one subsidiary - Nanoform USA Inc. The Group production, research and development functions operate in Finland. The Group’s strategy is to sell nanotechnological services widely to minimize the dependence from single customers or projects.

Show more

Earnings Calls

Show Transcript
Previous
Next
Loading

Management

Mr. Albert Alexander Haeggstrom
CFO & Director
No Bio Available
Prof. Edward Olof Haeggstrom
Co-Founder & CEO
No Bio Available
Mr. Henri von Haartman
Director of Investor Relations
No Bio Available
Mr. Peter Hanninen
General Counsel & Chief Development Officer
No Bio Available
Dr. David Rowe
Head of Manufacturing
No Bio Available
Mr. Christian Jones
Chief Commercial Officer
No Bio Available
Mr. Antonio Da Silva
Chief of Business Operations
No Bio Available
Ms. Johanna Kause
Chief Quality Officer
No Bio Available
Dr. Jamie Unwin
Vice President of Strategic Insight
No Bio Available

Contacts

Address
ETELA-SUOMEN
Helsinki
Cultivator II, Viikinkaari 4
Contacts
+358293700150
nanoform.com